Skip to content

A Study to Check if Prinkwellness Vaginal Capsules Are Safe and Effective for Reducing Period Pain

A Prospective, Single-Arm, Single-Centre Clinical Study To Evaluate The Safety And Efficacy Of Prinkwellness Vaginal Suppositories For The Management Of Menstrual Cramps - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080634
Enrollment
100
Registered
2025-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: vaginal suppositories: Administer 2 grams of vaginal suppositories intravaginally once during menstruation. Dosage: 1. First Cycle: Dosage-100 mg of vaginal suppository once during mens

Sponsors

HYD HEMP INDIA PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects willing to give informed consent. 2. Healthy female subjects between the age group of 18- 50 years. 3. Subjects not currently using any medications for menstrual pain relief. 4. History of at least 6 months of menstrual cramping pain which lasts for 2 days in each menstrual cycle.

Exclusion criteria

Exclusion criteria: 1. Subjects having any organic pathology of the uterus and adnexae. 2. HIV, VDRL, HBsAg positive Subjects. 3. Subjects suffering from systemic diseases. 4. Subjects with intra-uterine contraceptive devices. 5. Subjects with menorrhagia and metrorrhagia. 6. Subjects is having menstrual period interval less than 21 days or more than 35 days. 7. Pregnant and breastfeedin

Design outcomes

Primary

MeasureTime frame
1. To evaluate Change in Visual Analogue Scale score for pain intensity 2. To assess the safety of the vaginal suppositoriesTimepoint: Day1, Day30, Day60

Secondary

MeasureTime frame
1. To assess change in quality of life using the SF-36 Questionnaire.Timepoint: Day1, day3, Day 5 Day 15

Countries

India

Contacts

Public ContactArpita malgi

Samahitha Research Solutions

satyalm@samahitha.com9916252529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026